Recent Press Releases

IU study: Parents' vaccine intentions influenced by how benefits are communicated

INDIANAPOLIS -- How do parents decide whether to vaccinate their child? In a study designed to formally look at the content of parent-targeted communications about the benefits of vaccination for...

Vaccines can cut the spread of meningitis by nearly 40 per cent

Investigators at the University of Southampton have discovered that two new vaccines can prevent the transmission of meningitis bacteria from person to person. The vaccines do this by reducing...

Dengue Vaccine Market Set to Experience Rapid Growth from 2015 to 2020, says GlobalData

LONDON, UK (GlobalData), 16 July 2014 - Among the five major pharmaceutical markets (5MM: Brazil, India, Mexico, Singapore and Thailand), Brazil and Mexico are projected to be the leading...

Flublok® Influenza Vaccine Will Be Available At Over 230 Passport Health Locations Nationwide

MERIDEN, Conn. and SCOTTSDALE, Ariz., Aug. 19, 2014 /PRNewswire/ -- Protein Sciences Corporation and Passport Health announced today that Flublok® influenza vaccine will be available this fall...

FDA Approves Use of AFLURIA® Influenza Vaccine with PharmaJet's Needle-Free Injector

Jet injector device delivers single dose of injectable flu vaccine without a needle KING OF PRUSSIA, Penn. / GOLDEN, Colo. – [August 19, 2014] – PharmaJet® Inc., the developer of a...

​Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bivalent...

Advisory Committee on Immunization Practices Votes to Recommend Pfizer's Prevnar 13® Vaccine in Adults Aged 65 Years and Older

Wednesday, August 13, 2014 - 5:42pm EDT Pfizer Inc. (NYSE:PFE) today announced that the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP)...

Sanofi Pasteur Announces Publication of Positive Data for Fluzone® High-Dose Vaccine in The New England Journal of Medicine

LYON, France, Aug. 13, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi , today announced that The New England Journal of Medicine published positive results from a large-scale,...

Protein Sciences and Liomont Announce Licensing of Proprietary Influenza Vaccines for the Mexico Market

MERIDEN, Conn. and MEXICO CITY, Aug. 12, 2014 /PRNewswire/ -- Protein Sciences Corporation and Laboratorios Liomont, S.A. de C.V. (Liomont), a leading Mexican pharmaceutical company, announced today...

Kaiser Permanente Study Finds Shingles Vaccine Remains Effective After Chemotherapy

Previous vaccination lowers the risk of shingles among older patients undergoing chemotherapy by 42 percent PASADENA, Calif., Aug. 5, 2014 /PRNewswire/ -- The herpes zoster vaccine continues to be...

GeoVax Announces Clinical Development License Agreement with Valneva SE

Use of Valneva's EB66(R) Cell Line to Aid in Development of Commercial-Scale Manufacturing Process for GeoVax's HIV/AIDS Vaccine ATLANTA, GA, / ACCESSWIRE / August 6, 2014 / GeoVax Labs, Inc....

Specialty Vaccine Company PaxVax Expands Global Commercial Team

REDWOOD CITY, Calif., Aug 07, 2014 (BUSINESS WIRE) -- PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced the expansion of its global commercial team with the...

European Medicines Agency Accepts Application Seeking New Indication For Prevenar 13®1 For Prevention Of Pneumococcal Pneumonia In Adults

Application Includes Data from Pfizer's Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) NEW YORK, Aug 07, 2014 (BUSINESS WIRE) -- Pfizer Inc. PFE -0.46% announced today that...

First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development

AFFiRiS AG presents Phase I data on a first-of-its-kind treatment with support from The Michael J. Fox Foundation (NEW YORK, USA, VIENNA, Austria) July 31, 2014 — AFFiRiS AG announced today at...

New malaria vaccine candidates identified

Previously untested antigens found in large-scale study of patients in Kenya 30 July 2014--Researchers have discovered new vaccine targets that could help in the battle against malaria. Taking a new,...

Redbiotec and GE Healthcare Collaborate to Advance CMV Vaccine Development and Manufacturing

Companies combine expertise to produce cytomegalovirus vaccine candidates ZURICH, Jul 28, 2014 (BUSINESS WIRE) -- Redbiotec, a biopharmaceutical company specializing in vaccine development, has...

Variation Biotechnologies and Paulson Capital Announce Completion of Merger

-- Paulson Capital (Delaware) Corp. Changes Name to VBI Vaccines Inc. -- VBI Vaccines Inc. Shares to Trade on NASDAQ Under the Ticker Symbol "VBIV" at Market Open on...

PaxVax Acquires the FDA-Approved Typhoid Vaccine Vivotif

Deal Also Includes Manufacturing and Development Facility in Switzerland REDWOOD CITY, Calif., Jul 28, 2014 (BUSINESS WIRE) -- PaxVax, Inc., a specialty vaccine company focused on travel and...

Specialty Vaccine Company PaxVax Secures Up to $60 Million in Financing

Proceeds to Support New European Operations and Clinical Development, Regulatory Review and Anticipated Global Launch of Late-Stage Cholera Vaccine Candidate REDWOOD CITY, Calif., Jul 28, 2014...

Pfizer Enters Into Agreement To Acquire Baxter's Portfolio Of Marketed Vaccines

Wednesday, July 30, 2014 - 8:00am EDT Pfizer Inc. today announced that it has entered into a definitive agreement to acquire Baxter International Inc.'s portfolio of marketed vaccines for...